Cardiac Transthyretin Amyloidosis: Hidden in Plain Sight
Amyloidosis is an underappreciated medical condition with symptoms camouflaging as common medical comorbidities leading to its underdiagnosis due to its systemic involvement. Despite common misconceptions, amyloidosis and its systemic comorbidities are more prevalent and treatable than previously ac...
Saved in:
Main Authors: | Constantine N. Logothetis, Joel Fernandez, Damian A. Laber |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2021-01-01
|
Series: | Case Reports in Medicine |
Online Access: | http://dx.doi.org/10.1155/2021/2551964 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Serum Biomarkers in Transthyretin Amyloidosis: An Overview of Neurofilaments, Cardiac, Renal, and Gastrointestinal Involvement
by: Valeria Guglielmino, et al.
Published: (2025-01-01) -
Accuracy of Established Prognostic Staging Systems for Cardiac Transthyretin Amyloidosis in the Tafamidis Era
by: Maximilian Leo Müller, MD, et al.
Published: (2025-02-01) -
Hidden in Plain Sight? Corporate Strategic Litigation in the EU Emissions Trading System
by: Sofie Fleerackers
Published: (2024-08-01) -
Clinical features and predictors of atrial fibrillation in patients with light‐chain or transthyretin cardiac amyloidosis
by: Maria Papathanasiou, et al.
Published: (2022-06-01) -
Epidemiology of transthyretin (ATTR) amyloidosis: a systematic literature review
by: Diego Delgado, et al.
Published: (2025-01-01)